Why the study?
Despite advances in catheter ablation, some ventricular arrhythmias remain refractory, requiring a better understanding of the underlying substrate for internal and surgical ablation, especially in bundle branch reentrant ventricular tachycardia.
A comprehensive understanding of the underlying substrate is essential for selecting optimal internal or surgical ablation strategies to manage complex and refractory ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
May support combined endo-epicardial ablation in select VA patients; leaves open prospective RCTs for confirmation.
Catheter ablation is a crucial therapeutic approach for managing ventricular arrhythmias (VAs), offered improved outcomes over the last few decades. The strategy’s efficacy and safety have seen consistent enhancements, benefiting patients both with and without structural heart disease. Combining endocardial and epicardial ablation has proven valuable, particularly in nonischemic cardiomyopathy, myocardial infarction, arrhythmogenic right ventricular cardiomyopathy, and certain epicardially originating focal VAs. However, despite these advancements, some VAs remain refractory, leading to life-threatening electrical storms and increased mortality rates. Surgical epicardial ablation has emerged as a promising alternative for managing such challenging cases. Bundle branch reentrant ventricular tachycardia (VT), a specific form of sustained monomorphic VT, involves a reentry circuit comprising the distal His-Purkinje system, left and right bundle branches, and the proximal ventricular septum. This review underscores the significance of comprehending the underlying substrate in VAs necessitating internal and surgical ablation, particularly in the context of bundle branch reentrant VT. The discussion encompasses mapping strategies, clinical prognosis, and the identification of optimal ablation techniques. Through this comprehensive examination, clinicians can better navigate the complexities of VA management, ultimately improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Hongwu Chen (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: